The time dependency of inactivation of human cationic trypsin and chymotrypsin II and of bovine trypsin and alpha-chymotrypsin by human serum has been investigated. Since the molar concentration of serum alpha1-proteinase inhibitor is much higher than that of other inhibitors, this time dependence could be used to calculate the rate constants kass for the association of alpha1-proteinase inhibitor with the four proteases. The association process was found to be second order, with kass ranging from 1 x10(4) s-1 (human trypsin) to 2.6 x 10(6) s-1 (bovine chymotrypsin). The human proteases react much more slowly with human alpha1-proteinase inhibitor than the bovine ones. But, whatever the species, chymotrypsin is inhibited more quickly than trypsin. Addition of alpha2-macroblobulin to the inactive complexes resulted in a time-dependent regeneration of enzymic activity due to the formation of alpha2-macroglobulin-protease complexes. The reactivation (i.e. dissociation) process was first order and extremely slow: the half-life of the alpha1-proteinase inhibitor-proteinase complexes ranged from 8 days (bovine chymotrypsin) to 9 months (human chymotrypsin). The human proteases formed the most stable complexes with alpha1-proteinase inhibitor. The pathological implications of these findings are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/0009-8981(77)90070-5DOI Listing

Publication Analysis

Top Keywords

alpha1-proteinase inhibitor
20
human
8
inactivation human
8
bovine chymotrypsin
8
chymotrypsin human
8
human proteases
8
alpha1-proteinase
6
bovine
5
inhibitor
5
chymotrypsin
5

Similar Publications

Background: Alpha-1 antitrypsin (AAT)-deficient individuals have a greater risk for developing COPD than individuals with normal AAT levels.

Methods: This was a double-blind, randomised, parallel group, placebo-controlled trial to examine the safety and tolerability of "Kamada-AAT for Inhalation" (inhaled AAT) in subjects with AAT deficiency, and to explore its effect on AAT and biomarkers in the lung epithelial lining fluid (ELF). 36 patients with severe AAT deficiency were randomised 2:1 to receive 80 mg or 160 mg inhaled AAT or placebo once daily for 12 weeks.

View Article and Find Full Text PDF

Alpha-1 antitrypsin (AAT) deficiency (AATD) is a monogenic disease caused by misfolding of AAT variants resulting in gain-of-toxic aggregation in the liver and loss of monomer activity in the lung leading to chronic obstructive pulmonary disease (COPD). Using high-throughput screening, we discovered a bioactive natural product, phenethyl isothiocyanate (PEITC), highly enriched in cruciferous vegetables, including watercress and broccoli, which improves the level of monomer secretion and neutrophil elastase (NE) inhibitory activity of AAT-Z through the endoplasmic reticulum (ER) redox sensor protein disulfide isomerase (PDI) A4 (PDIA4). The intracellular polymer burden of AAT-Z can be managed by combination treatment of PEITC and an autophagy activator.

View Article and Find Full Text PDF

Corticosteroid binding globulin (CBG; SERPINA6) binds >85% of circulating glucocorticoids but its influence on their metabolic actions is unproven. Targeted proteolytic cleavage of CBG by neutrophil elastase (NE; ELANE) significantly reduces CBG binding affinity, potentially increasing 'free' glucocorticoid levels at sites of inflammation. NE is inhibited by alpha-1-antitrypsin (AAT; SERPINA1).

View Article and Find Full Text PDF

Neutrophil elastase (NE) is released by activated neutrophils during an inflammatory response and exerts proteolytic activity on elastin and other extracellular matrix components. This protease is rapidly inhibited by the plasma serine protease inhibitor alpha-1-antitrypsin (AAT), and the importance of this protective activity on lung tissue is highlighted by the development of early onset emphysema in individuals with AAT deficiency. As a serpin, AAT presents a surface-exposed reactive centre loop (RCL) whose sequence mirrors the target protease specificity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!